1. Home
  2. PLPC vs TNGX Comparison

PLPC vs TNGX Comparison

Compare PLPC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Preformed Line Products Company

PLPC

Preformed Line Products Company

HOLD

Current Price

$277.66

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$13.07

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLPC
TNGX
Founded
1947
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PLPC
TNGX
Price
$277.66
$13.07
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$14.33
AVG Volume (30 Days)
117.4K
2.8M
Earning Date
03-12-2026
02-27-2026
Dividend Yield
0.30%
N/A
EPS Growth
13.62
N/A
EPS
7.55
N/A
Revenue
$663,346,000.00
$66,501,000.00
Revenue This Year
$16.31
$52.63
Revenue Next Year
$13.74
N/A
P/E Ratio
$36.95
N/A
Revenue Growth
15.93
53.29
52 Week Low
$118.99
$1.03
52 Week High
$287.97
$13.48

Technical Indicators

Market Signals
Indicator
PLPC
TNGX
Relative Strength Index (RSI) 63.83 61.37
Support Level $270.20 $12.12
Resistance Level $287.97 $13.18
Average True Range (ATR) 12.94 0.79
MACD 1.03 -0.02
Stochastic Oscillator 83.70 76.61

Price Performance

Historical Comparison
PLPC
TNGX

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: